Literature DB >> 1999182

Regulation of the expression of the sex-specific isoforms of cytochrome P-450 in rat liver.

V Kobliakov1, N Popova, L Rossi.   

Abstract

The hepatic metabolism of steroid hormones and of xenobiotics frequently depends on the expression of the sex-specific isoforms of cytochrome P-450 and on differences in sex hormones. Following biochemical, immunological and molecular biological investigations, it was shown that in adult rat liver there exist at least four male-specific and one female-specific isoforms of cytochrome P-450. The designation of these sex-specific genes is IIC11, IIIA2, IIC13 and IIA2 in males, and IIC12 in females. The irreversible programming of the expression of these isoforms of cytochrome P-450 in adulthood occurs during the perinatal period of life, and is named enzyme imprinting. One of the main factors that regulates the expression of the sex-specific isoforms of cytochrome P-450 is the level of androgens in the blood. Castration of adult rats decreased the level of the male isoforms of cytochrome P-450 and the activity of the monooxygenase enzyme system that remained higher than in intact females. The mechanism of enzyme imprinting can be explained as follows: neonatal androgens program the secretion of hypothalamic hormones, somatostatin and growth-hormone-releasing factor. These factors determine the type of growth hormone secretion in adult rats, and this controls the type of sex-specific isoforms of cytochrome P-450 expressed in adulthood. Metabolic regulation similar to that outlined above was shown to occur for several metabolism-dependent chemical carcinogens. Such a pathway may explain the different sensitivity displayed by male and female rats to treatment with these carcinogenic agents. One possible way of modulating the expression of some isoforms of cytochrome P-450 in adult rats is by treating neonates with specific xenobiotics that change the constitutive expression of neonatal androgens. It appears that this enzyme imprinting plays an important role in determining the individual sensitivity to the carcinogenic effects of chemicals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999182     DOI: 10.1111/j.1432-1033.1991.tb15741.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  3-Methylcholanthrene (3-MC) and 4-chlorobiphenyl (PCB3) genotoxicity is gender-related in Fischer 344 transgenic rats.

Authors:  J A Jacobus; B Wang; C Maddox; H Esch; L Lehmann; L W Robertson; K Wang; P Kirby; G Ludewig
Journal:  Environ Int       Date:  2010-08-23       Impact factor: 9.621

2.  A novel vascular EET synthase: role of CYP2C7.

Authors:  Dong Sun; Houli Jiang; Hongyan Wu; YangMing Yang; Gabor Kaley; An Huang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-21       Impact factor: 3.619

3.  Treprostinil Improves Hepatic Cytochrome P450 Activity during Rat Liver Transplantation.

Authors:  Nisanne Ghonem; Junichi Yoshida; Noriko Murase; Stephen C Strom; Raman Venkataramanan
Journal:  J Clin Exp Hepatol       Date:  2012-10-12

4.  Nuclear receptor CAR specifically activates the two-pore K+ channel Kcnk1 gene in male mouse livers, which attenuates phenobarbital-induced hepatic hyperplasia.

Authors:  Kosuke Saito; Rick Moore; Masahiko Negishi
Journal:  Toxicol Sci       Date:  2013-01-04       Impact factor: 4.849

5.  In vivo and in vitro evidence of the sex-dependent pharmacokinetics and disposition of G004, a potential hypoglycemic agent, in rats.

Authors:  Linlin Hu; Janvier Engelbert Agbokponto; Xiaobing Li; Li Ding; Bing Liu; Shuisheng Zhong; Xiaoyu Zhang; Yiwei Du
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-04-03       Impact factor: 2.441

Review 6.  How subchronic and chronic health effects can be neglected for GMOs, pesticides or chemicals.

Authors:  Gilles-Eric Séralini; Joël Spiroux de Vendômois; Dominique Cellier; Charles Sultan; Marcello Buiatti; Lou Gallagher; Michael Antoniou; Krishna R Dronamraju
Journal:  Int J Biol Sci       Date:  2009-06-17       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.